10.1186/s12943-023-01716-y - CMTM6 overexpression confers trastuzu...

This document has been corrected

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer

10.1186/s12943-023-01716-y

Published Online: 2023-01-10

Journal: Molecular Cancer•Publisher: Springer Science and Business Media LLC

Authors: Caigang Liu•Fei Xing•Guanglei Chen•Hongli Gao•Jiayi Sun•Jinqi Xue•Lisha Sun•Xinbo Qiao

This document has been corrected

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer

10.1186/s12943-023-01716-y

Published Online: 2023-01-10

Journal: Molecular Cancer

Authors: Caigang Liu•Fei Xing•Guanglei Chen•Hongli Gao•Jiayi Sun•Jinqi Xue•Lisha Sun•Xinbo Qiao

NOW

2025-04-14•Correction

Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer

10.1186/s12943-025-02317-7